Published September 9, 2020
| Version v10
Working paper
Open
On the association of Hydroxychloroquine and Azithromycin in treating Covid-19 in Italy
Description
A survey of news and literature about the association of two drugs, hydroxychloroquine and azithromycin, in treating Covid-19 is proposed. In particular, the survey of news has been focussed on Italy, with the aim of understanding how large is the use of this association of drugs in the country. The recommendations of AIFA are also reported.
Files
Associat-9.pdf
Files
(353.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:8a41b6c98d86894f80769a9bd83a504c
|
353.3 kB | Preview Download |
Additional details
References
- AIFA - 8 April 2020 - https://web.archive.org/web/20200518071330/https://www.aifa.gov.it/documents/20142/1123276/azitromicina_08.04.2020.pdf/951fa605-0bf9-3882-ae2f-15128fe97a1b
- La Stampa - 16 April 2020 - https://web.archive.org/web/20200518071708/https://www.lastampa.it/salute/2020/04/16/news/clorochina-e-l-idrossiclorochina-a-ruba-nelle-farmacie-le-molecole-nemiche-del-coronavirus-1.38724080
- AIFA - 5 May 2020 - https://web.archive.org/web/20200518072136/https://www.aifa.gov.it/documents/20142/1123276/azitromicina_05.05.2020.pdf/272d910e-1f59-d69c-28f0-805f096ae4d3